172 related articles for article (PubMed ID: 6086193)
21. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
[TBL] [Abstract][Full Text] [Related]
22. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
[TBL] [Abstract][Full Text] [Related]
23. [Antihypertensive mechanism of oral angiotensin I converting enzyme inhibitor (captopril) in renin-independent essential hypertension].
Miyamori I; Takeda Y; Ikeda M; Koshida H; Yasuhara S; Morise T; Takimoto H; Takeda R; Nishino T
Nihon Naibunpi Gakkai Zasshi; 1983 Jun; 59(6):907-17. PubMed ID: 6311635
[TBL] [Abstract][Full Text] [Related]
24. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
Sassano P; Pedrinelli R; Magagna A; Abdel-Haq B; Salvetti A
Am J Cardiol; 1982 Apr; 49(6):1574-6. PubMed ID: 6280486
[TBL] [Abstract][Full Text] [Related]
25. Effects of long-term blockade of angiotensin converting enzyme with captopril on blood pressure and aortic prolyl hydroxylase activity in spontaneously hypertensive rats.
Oshima T; Matsushita Y; Miyamoto M; Koike H
Eur J Pharmacol; 1983 Jul; 91(2-3):283-6. PubMed ID: 6311581
[TBL] [Abstract][Full Text] [Related]
26. Kinetic studies of the pharmacologic response to captopril in rats. II. Hypotensive effect and plasma angiotensin converting enzyme activity.
Endoh M; Suzuki M; Katayama K; Kakemi M; Koizumi T
J Pharmacobiodyn; 1989 Jan; 12(1):10-7. PubMed ID: 2542517
[TBL] [Abstract][Full Text] [Related]
27. Blood pressure regulation by angiotensin in the spontaneously hypertensive rats.
Sokabe H; Kawashima K; Watanabe TX
Adv Exp Med Biol; 1979; 120B():429-35. PubMed ID: 390989
[TBL] [Abstract][Full Text] [Related]
28. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
29. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
Ogihara T; Maruyama A; Hata T; Mikami H; Nakamaru M; Naka T; Ohde H; Kumahara Y
Clin Pharmacol Ther; 1981 Sep; 30(3):328-35. PubMed ID: 6268347
[TBL] [Abstract][Full Text] [Related]
30. Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats.
Unger T; Kaufmann-Bühler I; Schölkens B; Ganten D
Eur J Pharmacol; 1981 Apr; 70(4):467-78. PubMed ID: 6263638
[TBL] [Abstract][Full Text] [Related]
31. Effects of subacute oral administration of captopril (SQ 14,255) on the renin-angiotensin system in spontaneously hypertensive rats.
Pong SF; Moore AF; Huang CT; Ellis KO
J Pharm Pharmacol; 1982 Mar; 34(3):186-7. PubMed ID: 6121897
[No Abstract] [Full Text] [Related]
32. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
[TBL] [Abstract][Full Text] [Related]
33. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
[TBL] [Abstract][Full Text] [Related]
34. Effects of chronic administration of an angiotensin-converting enzyme inhibitor on angiotensin-converting enzyme activity in the pars recta of rabbits.
Praddaude F; Tran-Van T; Marchetti J; Girolami JP; Ader JL
Clin Sci (Lond); 1990 Jul; 79(1):29-35. PubMed ID: 2167787
[TBL] [Abstract][Full Text] [Related]
35. Failure of captopril to lower blood pressure in spontaneously hypertensive rats offered water and saline to drink.
DiNicolantonio R
Clin Exp Pharmacol Physiol; 1983; 10(3):269-72. PubMed ID: 6354531
[TBL] [Abstract][Full Text] [Related]
36. Dose response in captopril therapy of hypertension.
Lijnen P; Fagard R; Staessen J; Verschueren LJ; Amery A
Clin Pharmacol Ther; 1980 Sep; 28(3):310-5. PubMed ID: 6250759
[TBL] [Abstract][Full Text] [Related]
37. SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
Unger T; Yukimura T; Marin-Grez M; Lang RE; Rascher W; Ganten D
Eur J Pharmacol; 1982 Mar; 78(4):411-20. PubMed ID: 6281036
[TBL] [Abstract][Full Text] [Related]
38. Hypotensive action of captopril and saralasin in intact and anephric spontaneously hypertensive rats.
Hutchinson JS; Mendelsohn FA; Doyle AE
Hypertension; 1980; 2(2):119-24. PubMed ID: 6991407
[TBL] [Abstract][Full Text] [Related]
39. Effects of chronic administration of captopril on blood pressure and the renin-angiotensin-aldosterone system in normotensive rats.
Ishii M; Goto A; Kimura K; Hirata Y; Yamakado M; Takeda T; Murao S
Jpn Heart J; 1983 Jul; 24(4):623-31. PubMed ID: 6358579
[TBL] [Abstract][Full Text] [Related]
40. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats.
Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H
Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
